The International Society of Aesthetic Plastic Surgery's (IMCAS) World Congress 2025 (IMCAS 2025), considered the largest academic event in the field of medical aesthetics, officially opened in Paris, France on the 30th.
This annual event brings together experts in dermatology, plastic surgery, and aging science to share cutting-edge knowledge in medical aesthetics. This year, more than 350 companies will showcase their latest products and technologies, and more than 900 speakers will give lectures.
Among them, Newpong attracted attention by introducing the ultrasonic medical device 'LLSA' at the site.
Elsa is a minimally invasive ultrasonic liposuction medical device equipped with the world's thinnest 0.9mm diameter probe. Through the 'Deep Sono Algorithm', a system that detects frequency in real time and always maintains a constant output, it is possible to treat delicate areas that were difficult to treat with existing liposuction medical devices, such as the face, floating breasts, calves, and double chin.
Newpong CEO Lee Jae-yong said, “The advantage of Elsa is that it has fewer side effects thanks to its thin probe and can be used on any part of the body without any burden.” He added, “We will use this as an opportunity to firmly establish ourselves as a safe medical device that is in line with the minimally invasive trend on the global stage.”
